metricas
covid
Buscar en
Enfermedades Infecciosas y Microbiología Clínica
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica Constitutional syndrome and miliary pattern in an HIV-positive patient
Información de la revista
Vol. 41. Núm. 7.
Páginas 443-444 (agosto - septiembre 2023)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Visitas
399
Vol. 41. Núm. 7.
Páginas 443-444 (agosto - septiembre 2023)
Scientific letter
Acceso a texto completo
Constitutional syndrome and miliary pattern in an HIV-positive patient
Síndrome constitucional y patrón miliar en un paciente HIV positivo
Visitas
399
Patricia Nadal-Baróna, María Teresa Martín-Gómeza,
Autor para correspondencia
, Joaquín Burgosb
a Microbiology and Parasitology Department, Hospital Universitari Vall d’Hebron, Barcelona, Spain
b Infectious Diseases Department, Hospital Universitari Vall d’Hebron, Barcelona, Spain
Este artículo ha recibido
Información del artículo
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Figuras (1)
Texto completo

Lung infections in highly immunocompromised individuals, including patients living with HIV not undergoing antiretroviral treatment (ART), have a diverse aetiology and overlapping clinical characteristics.1 This may hamper the diagnosis of coinfections.

We present a case of a 42-year-old Bolivian woman living with HIV, without antiretroviral therapy (ART), a 50 CD4+ cells/μL count, and a viral load of 6.6 log10 copies/mL. She was admitted at the Emergency Room complaining of fever, diarrhoea, vomits, and a 10kg loss of weight over the last 6 months after a 2 year-stage in her native country. Laboratory examinations showed hepatic alteration.

Thoracoabdominal CT scan revealed diffuse bilateral micronodular pattern suggestive of miliary tuberculosis, pulmonary cavities in the lower left lobe, and diffuse lymphadenopathies (Fig. 1A). Microbiological workup included conventional, fungal, and mycobacterial cultures from bronchoscopy specimens, Mycobacterium tuberculosis PCR, Pneumocystis spp. PCR, cryptococcal antigen test, serum β-d-glucan and detection of antibodies against dimorphic fungi and imported parasitic diseases. Serological, cryptococcal antigen and PCR tests were negative, whereas (1,3)-β-d-glucan was positive (28.50pg/mL).

Fig. 1.

Thoracoabdominal computed tomography scan showing diffuse bilateral micronodular pattern indicated by white arrows and pulmonary cavities in the upper segment of lower left lobe pointed by a black arrow (A). Conventional culture plates of bronchoscopy specimen after 4 days of incubation (B). Conventional culture plates of bronchoscopy specimen after 17 days of incubation (C). Black arrows point Rhodoccoccus hoagii colonies and white arrow points Histoplasma capsulatum colonies.

(0.11MB).

Empiric antitubercular therapy and anti-Pneumocystis prophylaxis were started but the patient progressively deteriorated suffering from asthenia, dyspnoea, night cough, and bilateral pleuritic pain.

After 4 days of incubation (5% blood agar, 5% CO2, 37°C), mucoid salmon-pink colonies identified as Rhodococcus hoagii (formerly Rhodococcus equi) by MALDI-TOF (bioMérieux),2 were isolated in culture plates of respiratory specimens (Fig. 1B). Levofloxacin and imipenem were added while rifampicine was kept.

As the hepatic alteration remained unexplained, a liver biopsy was performed. Two weeks later, the Pathology Department reported an acute granulomatous hepatitis, with abundant small yeast-like structures within the granulomas. Concurrently, brownish white yeast-like colonies became visible in the bronchoscopy specimens extended culture (Fig. 1C) corresponding to thin hyaline hyphae, small microconidia, and spiked spheric macroconidia. Histoplasma capsulatum identification was confirmed by MALDI-TOF. Histoplasma spp. PCR from deparaffinised hepatic tissue was positive.

The final diagnosis was disseminated histoplasmosis and R. hoagii pulmonary coinfection. She was started on amphotericin B, switching to oral itraconazole 18 days later, while she was kept on antimicrobial treatment against R. hoagii. Over the following year, clinical and radiological improvement was observed. Antitubercular treatment was withdrawn as presence of Mycobacteria spp. was not confirmed; anti-Pneumocystis prophylaxis, however, was kept until a CD4+ count >200cells/μL was reached and the viral load became undetectable.

Antitubercular therapy was promptly initiated as a 30% of AIDS without ART from Latin America and presenting miliary pattern have tuberculosis,3 a pattern similar to other granulomatous infections such as rhodococcosis, cryptococcosis, pneumocystosis and endemic fungal diseases.1 Upper lobe cavities may also be found in R. hoagii and fungal pneumonia.1 Multiple opportunistic infections have been described in 8% of Latin-American AIDS patients.4

In our country, patients living with HIV are rarely infected by intracellular pathogens like R. hoagii nowadays; besides, Histoplasmosis is infrequently seen in non-endemic countries, so physicians may not be familiar with their clinical presentation, increasing the risk of missing their diagnosis.5 Although R. hoagii explained the necrotizing pneumonia6 it did not fully explained the micronodular pattern and the clinical manifestation. A positive BD-glucan test, the risk of potential exposure in Bolivia along with a compatible chest imaging led us to search for endemic fungi.

H. capsulatum was reported by the laboratory 22 days after admission. In Europe, disseminated histoplasmosis, the most life-threatening form, is usually diagnosed in the setting of an advanced HIV infection.7

Microbiological confirmation in non-endemic regions is challenging. Combined detection of Histoplasma antigen in urine and serum, the most effective way to diagnose disseminated histoplasmosis, is not widely available out of endemic areas.8 Serology turns positive 4–8 weeks after infection9 but it may fail in immunocompromised patients, as was our case.8 The (1,3)-β-d-glucan serum antigen, although unspecific, is usually positive in disseminated forms.10 Cultures, remain the gold standard, but they lack quickness and sensitivity.8 Real-time PCR assays can reach a sensitivity around 90–95%. The Histoplasma PCR in respiratory specimens was negative in our patient; however, a positive result was obtained from liver biopsy. Extra-pulmonary specimens and combination of different tests may increase the diagnostic sensitivity.

Due to the wide range of opportunistic infections that may exist in AIDS, diagnostic tests should be used meticulously, as its yield may be suboptimal, multiple active infections may co-exist, and they may present with overlapping or atypical signs and symptoms. Imported infections should be taken into account in patients coming from endemic areas.

Funding

This work did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Ethical approval

The research was conducted ethically in accordance with the World Medical Association Declaration of Helsinki. The patient provided written informed consent for publication of this case report and all the accompanying images.

Conflict of interest

The authors have no conflicts of interest to declare.

References
[1]
M.J. Rosen.
Pulmonary complications of HIV infection.
Respirology, 13 (2008), pp. 181-190
[2]
P. Kämpfer, W. Dott, K. Martin, S.P. Glaeser.
Rhodococcus defluvii sp. nov., isolated from wastewater of a bioreactor and formal proposal to reclassify [Corynebacterium hoagii] and Rhodococcus equi as Rhodococcus hoagii comb. nov.
Int J Syst Evol Microbiol, 64 (2014), pp. 755-761
[3]
B. Crabtree-Ramírez, Y. Caro-Vega, B.E. Shepherd, B. Grinsztejn, M. Wolff, C.P. Cortes, et al.
Time to HAART initiation after diagnosis and treatment of opportunistic infections in patients with AIDS in Latin America.
PLOS ONE, 11 (2016), pp. e0153921
[4]
N. Medina, A. Alastruey-Izquierdo, D. Mercado, O. Bonilla, J.C. Pérez, L. Aguirre, et al.
Comparative performance of the laboratory assays used by a Diagnostic Laboratory Hub for opportunistic infections in people living with HIV.
[5]
H. Furrer.
Opportunistic diseases during HIV infection – things aren’t what they used to be, or are they?.
J Infect Dis, 214 (2016), pp. 830-831
[6]
D.M. Weinstock, A.E. Brown.
Rhodococcus equi: an emerging pathogen.
Clin Infect Dis, 34 (2002), pp. 1379-1385
[7]
H.R. Ashbee, E.G.V. Evans, H.R. Ashbee, E.G.V. Evans, M.A. Viviani, B. Dupont, et al.
Histoplasmosis in Europe: report on an epidemiological survey from the European Confederation of Medical Mycology Working Group.
Med Mycol, 46 (2008), pp. 57-65
[8]
M.M. Azar, C.A. Hage.
Laboratory diagnostics for histoplasmosis.
J Clin Microbiol, 55 (2017), pp. 1612-1620
[9]
L.J. Wheat, M.M. Azar, N.C. Bahr, A. Spec, R.F. Relich, C. Hage.
Histoplasmosis.
Infect Dis Clin North Am, 30 (2016), pp. 207-227
[10]
M. Saccente, G. Krishnan.
Comparison of blood (1→3)-β-d-glucan levels in AIDS-related Pneumocystis jirovecii pneumonia and AIDS-related progressive disseminated histoplasmosis.
Clin Infect Dis, 73 (2021), pp. 1100-1102
Copyright © 2023. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos